They found no significant increase in risk in those using GLP-1 agonist therapy
Semaglutide is a GLP-1 receptor agonist medication that is an active ingredient in medications (Ozempic and Wegovy) that helps regulate blood sugar levels, suppresses appetite, and promotes feelings of fullness
Patients with risk factors such as obesity, extended diabetes duration, or specific medication use might need extra monitoring
Amblard, M., Fehrentz, J
When you take GLP-1 weight loss medication, it: Slows gastric emptying : Food stays in your stomach longer, helping you feel full and satisfied Reduces appetite : Many people experience significantly decreased food cravings Improves insulin sensitivity : Your body becomes more efficient at processing sugar Stabilizes blood sugar : This helps prevent the energy crashes that can trigger overeating Beyond weight loss, many people report improved energy levels, better sleep, and reduced obsession with food
Figure 3 shows that the delivery of IGF-1 protein to each layer of cartilage plays a therapeutic role